TMG (Trimethylglycine/Betaine).

Homocysteine is remethylated either by betaine through BHMT or by 5-methyltetrahydrofolate through methionine synthase. The two routes back each other up, with the betaine route dominant in liver and kidney.

Methionine synthase needs methylcobalamin to move the folate methyl group onto homocysteine, and the BHMT route betaine feeds does not need B12 at all. Betaine therefore carries more of the load when B12 is low.

The alternative to remethylation is transsulfuration, where cystathionine beta-synthase and cystathionine gamma-lyase both require pyridoxal phosphate. Betaine recycles homocysteine while B6 supports its permanent removal toward cysteine.

Betaine is produced in the body by oxidising choline, so choline intake raises the betaine pool. Supplying betaine directly spares choline for phospholipid and acetylcholine synthesis.

When betaine donates a methyl group through BHMT it becomes dimethylglycine and then, after two further demethylations, glycine. Glycine is the endpoint of betaine's methyl donation.

Betaine remethylates homocysteine to methionine, which is then adenosylated to S-adenosylmethionine, the universal methyl donor. Betaine sits one step upstream of the donor itself.

Creatine synthesis consumes a large share of the body's S-adenosylmethionine at its final methylation step. Supplemental creatine lowers that demand while betaine refills the methyl pool serving it.

Betaine homocysteine methyltransferase is a zinc metalloenzyme that uses the metal to activate the homocysteine thiol. Zinc status is required for betaine to donate its methyl group.

MTHFR, which produces the methylfolate used by the folate-dependent remethylation route, is an FAD enzyme built on riboflavin. Riboflavin status shapes how much of the load betaine has to carry.

Surplus nicotinamide is cleared by N-methylation using S-adenosylmethionine, so large niacin doses draw down the same methyl pool. Betaine feeds that pool, which is why the two are formulated together.

The PEMT route builds phosphatidylcholine by transferring three methyl groups from S-adenosylmethionine onto phosphatidylethanolamine. Supplying phosphatidylcholine directly spares methyl groups that betaine helps replenish.

Betaine hydrochloride delivers the same betaine ion plus hydrochloric acid, so the betaine doses add together even though the salts serve different purposes. Listing both raises total betaine intake.

Homocysteine can be remethylated by two independent routes: the folate-dependent methionine synthase route and the betaine-homocysteine methyltransferase route that uses betaine as the methyl donor. Rajdl and colleagues gave folic acid and betaine in the same study and reported their effects on plasma homocysteine and dimethylglycine. Homocysteine is a biochemical marker, and a change in it is not itself a clinical outcome.

Betaine-homocysteine methyltransferase transfers one methyl group from betaine to homocysteine, and the product is methionine. Methionine is then adenosylated to S-adenosylmethionine, the methyl donor for most transmethylation reactions in the body. This is settled pathway biochemistry and needs no trial to state.

Converting methionine into S-adenosylmethionine requires methionine adenosyltransferase, which needs magnesium and ATP to run. Betaine can supply the methyl group that regenerates methionine, but the step that turns methionine into a usable methyl donor still depends on that cofactor. This is textbook enzymology.

Serine hydroxymethyltransferase moves a carbon from serine onto tetrahydrofolate, which is the principal entry point for one-carbon units into the folate cycle. Betaine feeds the same remethylation output through a folate-independent route. The two supply the same downstream demand from different directions.

Phosphatidylethanolamine N-methyltransferase uses three S-adenosylmethionine molecules to make one phosphatidylcholine, and the phosphatidylcholine made by that route is enriched in long-chain polyunsaturated fatty acids including DHA. Methyl group supply and long-chain fatty acid supply therefore meet at the same molecule. The connection is biochemical, not a measured combination result.

Endogenous carnitine synthesis starts with trimethyllysine, made by SAM-dependent methylation of protein-bound lysine, so carnitine production draws on the same methyl pool betaine helps refill. Supplemental carnitine bypasses that demand. The relationship explains why methyl donor status and carnitine status are discussed together.

Inositol and choline-family methyl donors have been formulated together as lipotropic combinations for decades, on the argument that both feed phospholipid assembly. Inositol enters phosphatidylinositol while betaine supports the methylation route to phosphatidylcholine. The pairing is convention with a mechanistic rationale, not a measured combination effect.

Betaine acts as an intracellular osmolyte and has been examined for endurance and power outcomes, while beta-alanine raises muscle carnosine and buffers intracellular acidity. They work through separate mechanisms, which is the argument for stacking them. Nothing here measured the two together.

A large concentrated dose of dairy protein delivers a methionine load, and methionine catabolism passes through homocysteine before it is either remethylated or committed to transsulphuration. Betaine supports the remethylation arm of that handling. The mechanism is well described; the practical size of the interaction at ordinary intakes has not been quantified here.

Methylenetetrahydrofolate reductase requires FAD, derived from riboflavin, to produce the 5-methyltetrahydrofolate used by the folate-dependent remethylation route. Betaine drives the alternative route that does not need folate or that flavin. Formulas addressing methylation cover both arms for that reason.